Enveda Raises $311M in Series E to Advance Nature-Derived AI Drug Trials
Enveda Secures $311 Million in Series E Funding Enveda has raised $311 million in Series E funding, bringing its valuation to $2 billion, a doubling in just 12 months since…
Enveda
1 primary articles · 0 secondary mentions